Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and prognostic implications of hypertensive response to exercise in patients with hypertrophic cardiomyopathy.
Lu DY, Ventoulis I, Liu H, Haileselassie B, Pozios I, Liang HY, Sorensen LL, Canepa M, Bavaro N, Phillip S, Abraham MR, Abraham TP. Lu DY, et al. Among authors: canepa m. Int J Cardiol Cardiovasc Risk Prev. 2023 Jan 13;16:200166. doi: 10.1016/j.ijcrp.2022.200166. eCollection 2023 Mar. Int J Cardiol Cardiovasc Risk Prev. 2023. PMID: 36874040 Free PMC article.
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA-HCM Investigators. Maron MS, et al. N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13. N Engl J Med. 2024. PMID: 38739079 Clinical Trial.
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis.
Fumagalli C, Zampieri M, Argirò A, Tassetti L, Rossi G, Musumeci B, Tini G, Russo D, Sclafani M, Cipriani A, Sinigiani G, Di Bella G, Licordari R, Canepa M, Vianello PF, Merlo M, Porcari A, Rossi M, Sinagra G, Rapezzi C, Di Mario C, Ungar A, Olivotto I, Perfetto F, Cappelli F. Fumagalli C, et al. Among authors: canepa m. Int J Cardiol. 2023 Dec 1;392:131346. doi: 10.1016/j.ijcard.2023.131346. Epub 2023 Sep 7. Int J Cardiol. 2023. PMID: 37689398
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations.
Russo D, Cappelli F, Di Bella G, Tini G, Porcari A, Cipriani A, Canepa M, Merlo M, Licordari R, Vianello PF, Zampieri M, De Michieli L, Scirpa R, Perfetto F, Sinagra G, Autore C, Rapezzi C, Musumeci MB. Russo D, et al. Among authors: canepa m. Int J Cardiol. 2023 Dec 15;393:131354. doi: 10.1016/j.ijcard.2023.131354. Epub 2023 Sep 9. Int J Cardiol. 2023. PMID: 37696363 Free article.
Corrigendum to "Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis" [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88-94].
Mascia G, Crotti L, Groppelli A, Canepa M, Merlo AC, Benenati S, Di Donna P, Bona RD, Soranna D, Zambon A, Porto I, Olivotto I, Parati G, Brignole M, Cecchi F. Mascia G, et al. Among authors: canepa m. Int J Cardiol. 2023 Feb 1;372:150. doi: 10.1016/j.ijcard.2022.10.163. Epub 2022 Nov 28. Int J Cardiol. 2023. PMID: 36456363 No abstract available.
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy.
Porcari A, Cappelli F, Nitsche C, Tomasoni D, Sinigiani G, Longhi S, Bordignon L, Masri A, Serenelli M, Urey M, Musumeci B, Cipriani A, Canepa M, Badr-Eslam R, Kronberger C, Chimenti C, Zampieri M, Allegro V, Razvi Y, Patel R, Ioannou A, Rauf MU, Petrie A, Whelan C, Emdin M, Metra M, Merlo M, Sinagra G, Hawkins PN, Solomon SD, Gillmore JD, Fontana M. Porcari A, et al. Among authors: canepa m. J Am Coll Cardiol. 2024 Jun 18;83(24):2411-2422. doi: 10.1016/j.jacc.2024.03.429. J Am Coll Cardiol. 2024. PMID: 38866445 Free article.
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.
Bertero E, Chiti C, Schiavo MA, Tini G, Costa P, Todiere G, Mabritto B, Dei LL, Giannattasio A, Mariani D, Lofiego C, Santolamazza C, Monda E, Quarta G, Barbisan D, Mandoli GE, Mapelli M, Sguazzotti M, Negri F, De Vecchi S, Ciabatti M, Tomasoni D, Mazzanti A, Marzo F, de Gregorio C, Raineri C, Vianello PF, Marchi A, Biagioni G, Insinna E, Parisi V, Ditaranto R, Barison A, Giammarresi A, De Ferrari GM, Priori S, Metra M, Pieroni M, Patti G, Imazio M, Perugini E, Agostoni P, Cameli M, Merlo M, Sinagra G, Senni M, Limongelli G, Ammirati E, Vagnarelli F, Crotti L, Badano L, Calore C, Gabrielli D, Re F, Musumeci G, Emdin M, Barbato E, Musumeci B, Autore C, Biagini E, Porto I, Olivotto I, Canepa M. Bertero E, et al. Among authors: canepa m. Eur J Heart Fail. 2024 Jan;26(1):59-64. doi: 10.1002/ejhf.3120. Epub 2024 Jan 2. Eur J Heart Fail. 2024. PMID: 38131253 Clinical Trial.
Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].
Canepa M, Leporatti L, Persico L, Ameri P, Porto I, Ansaldi F, Montefiori M. Canepa M, et al. Int J Cardiol. 2023 Mar 1;374:135. doi: 10.1016/j.ijcard.2023.01.016. Epub 2023 Jan 20. Int J Cardiol. 2023. PMID: 36681564 No abstract available.
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials.
Tomasoni D, Bonfioli GB, Aimo A, Adamo M, Canepa M, Inciardi RM, Lombardi CM, Nardi M, Pagnesi M, Riccardi M, Vergaro G, Vizzardi E, Emdin M, Metra M. Tomasoni D, et al. Among authors: canepa m. Front Cardiovasc Med. 2023 May 23;10:1154594. doi: 10.3389/fcvm.2023.1154594. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37288260 Free PMC article. Review.
335 results